Form D/A — Lapix Therapeutics Inc.
0001947620-25-000001 · filed Feb 10, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $6,000,000
- Reported amount sold
- $5,520,946
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lapix Therapeutics Inc.
- CIK
- 1947620
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 271 Cambridge St., 2nd Floor
Cambridge, MA 02141 - Phone
- 8582264717
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Anas Fathallah · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Jason Norris · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Anthony Gibney · DirectorCambridge, MA Find on LinkedIn ↗
-
Henry McKinnell · DirectorCambridge, MA Find on LinkedIn ↗
-
Francisco Leon · DirectorCambridge, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗